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Myelinosome formation represents an early stage
of oligodendrocyte damage in multiple sclerosis
and its animal model
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Oligodendrocyte damage is a central event in the pathogenesis of the common neuroin-
ﬂammatory condition, multiple sclerosis (MS). Where and how oligodendrocyte damage is
initiated in MS is not completely understood. Here, we use a combination of light and electron
microscopy techniques to provide a dynamic and highly resolved view of oligodendrocyte
damage in neuroinﬂammatory lesions. We show that both in MS and in its animal model
structural damage is initiated at the myelin sheaths and only later spreads to the oligoden-
drocyte cell body. Early myelin damage itself is characterized by the formation of local myelin
out-foldings—‘myelinosomes’—, which are surrounded by phagocyte processes and
promoted in their formation by anti-myelin antibodies and complement. The presence of
myelinosomes in actively demyelinating MS lesions suggests that oligodendrocyte damage
follows a similar pattern in the human disease, where targeting demyelination by therapeutic
interventions remains a major open challenge.
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A
lthough demyelination is a deﬁning hallmark of multiple
sclerosis (MS) and underlies the chronic impairment of
axonal conduction in this disease, the cellular mechanisms
of immune-mediated oligodendrocyte damage remain enigmatic1.
For example, where neuroinﬂammatory damage is initiated along
the extended geometry of an oligodendrocyte is unclear2, that is,
whether at the cellular scale such damage spreads ‘centrifugally’
(from the oligodendrocyte cell body to myelin3) or rather
‘centripetally’ (from myelin to the soma4). Similarly, the earliest
signs of demyelination in MS lesions are still unresolved. In
principle, two different patterns could be posited: myelin damage
could start at the myelin surface, where myelin is exposed
to humoral and cellular immune mediators, or alternatively,
pathology could ﬁrst affect the myelin-axon adhesion, and hence
the most distal extent of the oligodendrocyte. Further-
more, such myelin changes could be initiated focally at isolated
sites on a myelin sheath or act segmentally affecting a larger
stretch of myelin simultaneously, such as an entire internode.
Disambiguating such possibilities is important to formulate clear
molecular hypotheses about the mechanisms underlying
oligodendrocyte damage and hence to build a rational
foundation for future therapeutic approaches to prevent
demyelination.
In vivo imaging has been a powerful analytical approach to
resolve cell biological disease mechanisms in the intact nervous
system. In the context of neuroinﬂammation, it has been applied
to resolve the initiation of neuronal damage5,6, the subcellular
correlate of axonal damage7, as well as at the immune cell
dynamics that represent the proximate cause of these neuronal
changes8. However, so far in vivo imaging has not been used to
explore the cellular dynamics underlying neuroinﬂammatory
oligodendrocyte damage.
Here, we take advantage of multi-spectral two-photon imaging
of axons, oligodendrocytes and myelin in the intact spinal cord,
viral labelling of single oligodendrocytes, correlated light and
electron microscopy and immune modulation approaches, to
show in mouse models of MS: (1) that the initial site of immune
attack appears to be myelin rather than the oligodendrocyte soma
and that damage then spreads centripetally, (2) that one of the
early signs of demyelination is the focal formation of bulb-like
structures, which we call myelinosomes, that appear on the
surface of the myelin sheath and (3) that formation of such
myelinosomes is promoted by anti-myelin antibodies and
abrogated by complement depletion, compatible with a model
of surface opsonization of myelin. Finally, this cellular mechan-
ism of oligodendrocyte damage seems to be also operational in
MS lesions, as we ﬁnd the same sequence of oligodendrocyte
damage, as well as evidence of myelinosome formation by high-
resolution confocal imaging of actively demyelinating MS lesions.
Results
Demyelination precedes oligodendrocyte loss in an MS model.
To understand where along the oligodendrocyte’s extent damage
is initiated during neuroinﬂammation, we ﬁrst quantiﬁed distinct
aspects of oligodendrocyte pathology in an animal model of MS,
experimental autoimmune encephalomyelitis (EAE). For this
purpose, we induced EAE in Biozzi ABH mice by active immu-
nization with the myelin oligodendrocyte glycoprotein (MOG). In
this model, which recreates key histopathological features of MS,
the mice initially develop relapses, which later give way to a
steady progression of the disease9. To reliably visualize oligo-
dendrocyte cell bodies, we crossed Biozzi ABH with PLP-GFP/
BL6 mice, in which the expression of GFP is driven by the PLP
promoter, thus allowing the visualization of oligodendrocytes and
their processes10. Experiments were performed with F1 hybrids,
in which the clinical course and histopathological appearance of
the disease is similar to wild-type Biozzi ABH mice (Supple-
mentary Fig. 1). We perfused mice at different time-points during
the course of EAE (at weight loss, at the onset of clinical
symptoms, two days after the onset and at a chronic time-point,
20 days after onset of the progressive disease phase) and used
confocal microscopy to determine the number of oligoden-
drocytes, as well as myelin density (based on MBP staining) in
relation to the local inﬁltration density (based on Neurotrace
staining). Our analysis showed that the proportion of lost myelin
exceeded the percentage of oligodendrocyte loss throughout the
course of EAE. For example, already nearly half of the myelin was
lost in lesions analyzed during the initial stages of the disease,
while oligodendrocyte numbers were unchanged at this time.
Likewise, at the peak of disease activity (2 days after onset of
clinical symptoms) myelin loss appeared to be the predominant
alteration in all areas of a neuroinﬂammatory lesion (Fig. 1a–c):
In the lesion centre (deﬁned by a high density of inﬁltrating cells)
myelin was largely lost, while more than half of the
oligodendrocyte cell bodies were still present. Likewise, in lesion
areas with only a moderate or low number of inﬁltrating immune
cells, we observed a substantial decrease of myelin density in the
absence of measureable oligodendrocyte loss. To conﬁrm at the
single-cell level that the spread of oligodendrocyte damage indeed
follows a centripetal pattern, we established a low-cellular density
labelling approach based on the injection of a diluted mCherry-
expressing rabies virus11. When injected into the lumbar dorsal
columns of PLP-GFP/Biozzi ABH spinal cords this technique
allowed us to reconstruct single oligodendrocytes and their
processes using confocal microscopy. Quantitative analysis
revealed that oligodendrocytes in spinal EAE lesions preserved
shorter and fewer processes than oligodendrocytes in healthy
mice (Fig. 1d–g). In line with these observations in ﬁxed tissue,
in vivo two-photon imaging of single-labelled oligodendrocytes at
different stages of the neuroinﬂammatory lesion revealed that
progressively shorter and less oligodendrocyte processes were
observed, conﬁrming the centripetal progression of
oligodendrocyte pathology (Supplementary Fig. 2). During
time-lapse recordings of several hours, almost no changes were
observed, suggesting that oligodendrocytes stably persisted for
longer periods of time despite extensive damage to their
processes. Moreover, this ‘amputated’ state appears not to be an
immediate step towards cell loss, as during our in vivo imaging
experiments, we did not see any cell die (total of 100 h of imaging
of 20 oligodendrocytes in 18 mice).
Taken together, these results point to a sequence of damage
that starts with myelin loss followed by degeneration of
oligodendrocyte processes and only in some cases, cell death.
One conclusion from these results is that to understand how
neuroinﬂammatory oligodendrocyte damage is initiated, we have
to focus on the myelin sheaths themselves.
In vivo imaging reveals formation of myelinosomes. To directly
visualize early signs of neuroinﬂammatory myelin damage, we
induced EAE in Thy1-YFP16/Biozzi ABH mice, in which many
spinal axons are marked by YFP12, and labelled myelin by local
application of MitoTracker Red (which acts as a lipophilic myelin
dye at the concentration used13). We then imaged regions of
active inﬂammation (identiﬁed based on the accumulation of
immune cells labelled with the vital dye Popo-1-Iodide13) in the
superﬁcial dorsal spinal cord by in vivo two-photon microscopy
(Fig. 2a). In the resulting time-lapse movies, we could in some
cases (n¼ 13) observe the de novo formation of bulb-like myelin
structures, which we refer to as ‘myelinosomes’ (adopting a
nomenclature used for fragments shed by other cells14). These
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myelinosomes appeared at discrete spots along the internode and
gradually lifted off the parent axons, in the process sometimes
forming a myelin dye-labelled inclusion sandwiched between the
myelin out-folding and the axon (Fig. 2b; Supplementary
Movie 1). Subsequent confocal microscopy analysis of ﬁxed
EAE tissue stained with an anti-MBP antibody conﬁrmed
the presence of myelinosomes in neuroinﬂammatory lesions
independently of in vivo imaging and vital dye application.
A particularly high density of myelinosomes was present during
active inﬂammation 2 days after EAE onset, as well as at 2 days
following the onset of EAE progression. Myelinosomes were still
present, albeit at a lower density, during the chronic phase of the
disease (Fig. 2c). Further analysis revealed that myelinsomes are
not only present in the Biozzi EAE model, but are also observed
in Thy1-YFP16 mice on a C57BL/6 background (Thy1-YFP16/
BL6) immunized with recombinant rodent or human MOG (EAE
induced by rodent MOG in Thy1-YFP16/BL6 mice: 1±0.1
myelinosomes/mm axon at Onsetþ 2 days; n¼ 5 mice, 252 axon
segments with 9mm of total axon length were evaluated; EAE
induced by human MOG in Thy1-YFP16/BL6 mice: 1.5±0.6
myelinosomes per mm axon at Onsetþ 2 days; n¼ 3 mice, 286
axon segments with 6.9mm total axon length were evaluated).
In contrast, such structures were observed neither in healthy
control animals (Fig. 2c), nor in a centrifugal model of oligo-
dendrocyte pathology induced by the injection of ethidium
bromide into the lumbar spinal cord (0±0 myelinosomes; n¼ 3
healthy mice, 217 axon segments, 5mm total axon length;
likewise 0±0 myelinosomes were observed in 3 saline-injected
mice, 183 axon segments, 4.1mm total axon length; Supple-
mentary Fig. 3).
To understand the ultrastructure of myelinosomes, we used the
near infrared branding (NIRB) technique15 to reconstruct
myelinosomes identiﬁed under the light microscope by serial
sectioning transmission electron microscopy (Fig. 2d–f). The
ultrastructural analysis conﬁrmed that myelinosomes, as well as
the myelin dye-positive inclusions, are composed of structures
that showed the membrane layering characteristic of compacted
myelin. To better visualize internal myelin ultrastructure, we
analyzed high-pressure frozen samples of neuroinﬂammatory
lesions induced in Biozzi ABH mice. This analysis revealed
two morphological features that subcategorize myelinosomes:
(i) myelin outfolding could either result from the detachment of
the entire myelin sheath from the axon surface or a splitting of
the myelin sheets, resulting in myelinosomes comprised of only
some superﬁcial myelin leaﬂets (typically including about 50% of
the myelin thickness); (ii) some myelinosomes contained myelin
inclusions inserted either between the axon and the detached
myelin or between ﬂared myelin sheaths (Fig. 2g–i; Supple-
mentary Fig. 4). Such ultrastructural myelin changes appear to be
speciﬁc for immune-mediated oligodendrocyte damage, as they
are essentially absent in a model of toxic demyelination induced
by the copper chelator cuprizone (one structure resembling a
myelinosome was observed in 181 myelin proﬁles in the corpus
callosum from 6 mice, half of which were examined at 2 or 3
weeks of cuprizone treatment, respectively, versus no myelino-
somes in 172 myelin proﬁles in the corpus callosum of 3 control
mice; cf. 16 myelinosomes that were observed in 115 myelin
proﬁles in the spinal cord from 3 EAE mice versus none in 125
myelin proﬁles in the spinal cord of 3 control mice).
Antibody–complement complexes promote myelinosome for-
mation. To identify potential immune mediators that can induce
myelinosome formation, we ﬁrst investigated the cellular envir-
onment of myelinosomes in electron microscopy reconstructions.
We found that in our samples, myelinosomes were often in the
immediate vicinity of phagocytes, which in some cases engulfed
the myelinosomes (Fig. 3a; Supplementary Movie 2). To
better characterize the phagocyte population surrounding sites of
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Figure 1 | Centripetal spread of oligodendrocyte damage in EAE lesions.
(a,b) Low magniﬁcation views of spinal cord sections of PLP-GFP/Biozzi
ABH mice (oligodendrocytes labelled with GFP, green; nuclei with NT, cyan;
myelin with MBP, magenta). In EAE (b) compared with healthy controls
(a) invading immune cells and myelin disruption are apparent.
(c) Quantiﬁcation of oligodendrocyte number (green bars) and myelin
length (magenta bars) at different time-points (Weight loss, n¼ 3 mice;
Onset, n¼ 3 mice; Onsetþ 2, n¼ 6 mice; Onset of progressionþ 20 days,
OnsetPþ 20, n¼ 3 mice) and related to inﬁltration density in lesions
analyzed at Onsetþ 2 days (n¼ 6 mice). All values are shown as
percentage of control (n¼ 3 mice). (d–g) Three-dimensional renderings of
confocal image stacks of single oligodendrocytes infected with rabies virus
in PLP-GFP/Biozzi ABH mice, revealing oligodendrocyte process damage in
EAE (e) compared with healthy controls (d) that affects both the length
(f) and number of processes (g; n¼8 oligodendrocytes for each group).
Insets below in d,e show the respective oligodendrocyte somata.
(a,b) Scale bar, 25mm; (d,e) Scale bar, 100mm (rendering) and 20mm
(inset). ***Po0.001 (f, P¼0.0001; g, P¼0.0007; t-test).
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myelinosome formation, we induced EAE in CCR2RFP/þ /Biozzi
ABH mice. In this knock-in mouse strain monocyte-derived
macrophages, the primary phagocyte population associated with
demyelination in EAE16, are labelled with RFP. We perfused mice
at the peak of disease activity (2 days after onset) and
counterstained the tissue for MBP to detect myelinosomes. To
probe whether macrophages are more likely to interact with
myelinosomes than morphologically unaffected myelin, we
compared the probability of a macrophage to be in close
apposition (o1mm distance) to a myelinosome to the
probability of a phagocyte contact on the opposite side of the
axon (where due to the low density of myelinosomes, such a
structure is typically absent). Our confocal analysis showed that
83.7% of the myelinosomes examined (n¼ 43 myelinosomes
from four mice) were in close apposition with blood-derived
macrophages (RFPþ cells), while only 34.9% of the (unaltered)
myelin on the other side showed such appositions. To further
assess the potential contribution of tissue-resident microglia cells
to myelinosome formation, we counterstained additional tissue
sections with the phagocyte marker Iba1. Here, none of the
myelinosomes examined (n¼ 15 myelinosomes from three mice)
were in contact with microglial cells (Iba1þ /RFP cells), while
in 20% of the cases microglia cells were found in close apposition
with the corresponding unaffected side of the axon. Taken
together, these analyses suggest a preferential association of
myelinosomes and blood-derived macrophages.
One candidate mechanism that could initiate such a macro-
phage-mediated immune attack against myelin is the humoral
immune response. To directly test whether anti-myelin antibodies
can induce myelinosome formation, we induced EAE in
Thy1-YFP16/BL6 mice by immunization with MOG35–55 peptide.
In this variant of EAE, B cells and antibodies play only a minor
role and primary demyelination is limited17. Demyelination
can however be substantially enhanced by the transfer of the
MOG-reactive monoclonal antibody, 8.18C5 (ref. 18). Indeed, in
this EAE model, we found a comparably low density of
myelinosomes, while anti-MOG antibody transfer not only
increased the area of demyelination, but also the local density
of myelinosomes within the demyelinated area (Fig. 3b,c). At the
same sites, T cells and macrophage densities were not
signiﬁcantly altered (Supplementary Fig. 5). These experiments
indicate that anti-myelin antibodies can induce the formation of
myelinosomes in a neuroinﬂammatory environment, and raise
the question how such antibodies prime phagocyte activation.
One possible intermediate of such phagocyte priming could be
the activation of complement components by myelin-bound
antibodies19. To probe the involvement of this mechanism in
myelinosome formation, we treated Thy1-YFP16/BL6 mice with
Cobra Venom Factor (CVF) to deplete complement20 and in
parallel induced myelinosome formation by transfer of the
8.18C5 antibody. Complement depletion prevented antibody-
induced myelinosome formation in areas of demyelination
(Fig. 3b,c), again leaving inﬁltration densities unaffected (Supple-
mentary Fig. 5). In line with previous work18, complement
depletion also reduced the overall size of the demyelinated area.
Together these results indicate that antibody–complement
complexes play an important role in the initiation of myeli-
nosome formation and subsequent myelin loss in neuro-
inﬂammatory lesions.
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Figure 2 | In vivo imaging and correlated electron microscopy reveal
myelinosome formation in acute neuroinﬂammatory lesions. (a) In vivo
image of an acute EAE lesion in a Thy1-YFP16/Biozzi ABH mouse revealing
swollen axons and disrupted myelin sheaths in areas of cell inﬁltration
(axons, white; nuclei, cyan; myelin, magenta throughout the ﬁgure).
(b) In vivo time-lapse showing the formation of a myelin out-folding
(‘myelinosome’) along an EAE axon. (c) Confocal image of a myelinosome
stained for myelin (MBP) in a Thy1-YFP16/Biozzi ABH mouse perfused at
2 days after EAE onset. The graph shows the density of myelinosomes per
mm axon at different time-points of EAE (healthy control, n¼ 3 mice, 254
axons segments with 6.27mm of total axon length were evaluated;
Onsetþ 2, n¼6 mice, 449 axon segments with 15.8mm of total axon
length were evaluated; Onset of Progressionþ 2, OnPþ 2, n¼ 3 mice, 238
axon segments with 9.1mm of total axon length were evaluated; Onset of
progressionþ 20, OnPþ 20, n¼ 5 mice, 480 axon segments with 16.6mm
of total axon length were evaluated). (d) ‘Near infrared branding’ marks
(dark lines) allow correlated ultrastructural reconstructions of
myelinosomes (the boxed example is reconstructed in e and magniﬁed in
inset). (e) Three-dimensional rendering of the myelinosome shown in d.
(f) Single ultrathin section through the centre of the myelinosome, showing
the detachment of myelin (pseudocoloured magenta) from the axon, and
inclusion of a myelin sphere inside (inset). (g–i) Electron micrographs from
high-pressure frozen spinal EAE tissue illustrating the presence of
myelinosomes that encompass all myelin leaﬂets (g), that show splitting of
the myelin sheaths (h) and that contain internal myelin structures (i).
(a) Scale bar, 50mm; (b,c) Scale bar, 5 mm; (d) Scale bar, 20mm (overview)
and 10 mm (inset); (e) Scale bar, 1mm (scale cube); (f (inset)) Scale bar,
200 nm; (g,h) Scale bar, 2mm; (i) Scale bar, 1mm.
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Myelinosomes are present in actively demyelinating MS lesions.
To investigate whether myelinosome formation is also an early
step of oligodendrocyte damage in the human disease, we
analyzed actively demyelinating lesions in brain biopsies from MS
patients (Supplementary Table 1). To determine, whether
in MS oligodendrocyte damage followed a ‘centripetal’ pattern,
we used the same approach as in EAE (cf. Fig. 1) and performed
triple immuno-labelling to reveal oligodendrocytes (stained
for NogoA), myelin (MBP) and microglia/macrophages (Iba1)
on sections counterstained with the nuclear dye DAPI
(Fig. 4a; Supplementary Fig. 6). Quantitative analysis of early
active lesions21 showed that myelin was almost completely lost in
the centre and substantially reduced at the rim region of the
lesion, while it was preserved in the normal-appearing white
matter (NAWM). In contrast, the density of NogoA-positive
oligodendrocytes was comparable between the lesion areas and
the adjacent NAWM (Fig. 4b–e). These results are consistent with
a centripetal spread of damage in oligodendrocytes located in
active MS lesions, that is damage that primarily affects myelin
integrity, and only to a lesser extent oligodendrocyte survival.
To determine whether oligodendrocyte damage in actively
demyelinating MS lesions is also accompanied by myelinosome
formation, we imaged myelin sheaths with higher resolution in
brain sections immunostained for MBP and neuroﬁlament
(NF200). We detected focal myelin out-foldings that met the
morphological criteria for myelinosomes as dynamically observed
and ultrastructurally corroborated in the EAE model (Fig. 4f).
Myelinosome density was elevated in the lesion area compared
with the adjacent NAWM. No myelinosomes were present in the
white matter of control brain sections from patients without
neuroimmunological disease or in brain lesions of patients
suffering from progressive multifocal leukoencephalopathy
(PML), a disease, in which a viral attack results in oligoden-
drocyte death22 (Fig. 4g; Supplementary Fig. 6). Thus, also in MS,
myelin damage corresponds to the presence of focal changes akin
to myelinosomes, suggesting the occurrence of a local immune
attack mediated by the abundant mononuclear phagocytes found
in areas of active demyelination in MS (Fig. 4b,e).
Discussion
Damage to oligodendrocytes and their myelin sheaths is the
pathological hallmark of MS lesions. Here, we show that changes
in oligodendrocyte morphology in neuroinﬂammatory lesions
proceed from the outside-in—resulting in oligodendrocytes that
have less and shorter processes. Remarkably, oligodendrocytes
appear to be able to survive in this amputated state for extended
periods of time, potentially preserving their ability to reform
myelin sheaths. While the morphological consequence of a
neuroinﬂammatory attack is thus the selective loss of the
peripheral oligodendrocyte compartments, this does not exclude
a predisposing global incapacitation of the affected oligoden-
drocytes, for example, due to an altered metabolic state or
disrupted ion balance due to a toxic inﬂammatory milieu (a state
of the oligodendrocyte that could be described as a ‘dying-back
oligodendrogliopathy’2,23,24). Indeed the ability of therapeutic
strategies that primarily target oligodendrocyte survival and
function to also limit demyelination would argue for such a
predisposing effect25,26. In the MS models and brain biopsies we
investigated here, the centripetal pattern of oligodendrocyte
damage we observed appears to be initiated at discrete sites on the
surface of myelin sheaths, where in parallel to the progress of
demyelination, local out-foldings—myelinosomes—are found.
Electron microscopy analysis using high-pressure frozen
samples to optimally preserve myelin morphology27,28 and
serial sectioning electron microscopy for 3D reconstruction14,15
revealed that myelinosomes can be classiﬁed into several ultra-
structural subtypes. In some cases, the entire myelin sheaths was
detached from the underlying axon, while in other cases only the
upper half of the myelin leaﬂets was lifted off, resulting in split
myelin sheaths. Both of these patterns were sometimes accom-
panied by myelin inclusions. At least some of these phenomena
could be explained by the recent insight that myelin basic protein
(MBP), the major protein component of the myelin sheath,
transitions from a soluble phase to a cohesive network to allow
myelin compaction29. Such a protein phase transition could be
locally reversed by pathological impact, allowing individual
myelin leaﬂets to separate and collapse into myelin bulbs30.
Bulb-like myelin structures have indeed been noted in a
number of situations, where myelin sheaths are attacked
or remodelled, for example, in peripheral neuropathies such as
Charcot–Marie–Tooth type 4H31, in animal models of
dysmyelination32, as well as, already previously, in MS and its
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Figure 3 | Myelinosome formation is mediated by antibody opsonization
and macrophage engulfment. (a) Three-dimensional electron microscopy
reconstructions reveal that myelinosomes (here examples composed of a
few myelin leaﬂets; pseudocoloured in magenta) are surrounded by cells
that show the ultrastructural hallmarks of phagocytes (pseudocoloured in
cyan and blue). Single electron microscopy planes of the myelinosomes are
shown on the right. (b,c) Anti-myelin antibodies and complement initiate
demyelination and myelinosome formation as revealed by LFB/PAS
stainings (b; myelin, blue) to assess the area of demyelination and confocal
microscopy analysis of MBP-immunostained sections to quantify
myelinosome density, both performed in EAE animals (Thy1-YFP16/BL6)
treated with anti-MOG antibody (8.18C5) without or with complement
depletion (cobra venom factor, CVF; for the area of demyelination were
analyzed: n¼ 11 mice injected with IgG1 isotype control antibody, n¼ 11
mice treated with 8.18C5 and n¼4 mice receiving CVFþ 8.18C5; for the
quantiﬁcation of density of myelinosomes were analyzed: n¼ 14 mice
injected with IgG1 isotype control antibody, n¼ 15 mice treated with 8.18C5
and n¼ 8 mice receiving CVFþ 8.18C5). (a) Scale bar, 1mm (cube), and
1mm (insets); (b) Scale bar, 50mm. *Po0.05; **Po0.01 (for analysis of
demyelinated area: Kruskal–Wallis followed by Dunn’s multiple comparison
test; for analysis of myelinosomes formation: one-way ANOVA followed by
Bonferroni’s multiple comparison tests).
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animal model16,33–35. Similar alterations also occur during
development when excess myelin is formed, for example, in the
optic nerve27. Still, when we analyzed models where the site of
initial injury is expected to be at the oligodendrocyte soma
(for example, ethidium bromide and cuprizone intoxication of
oligodendrocytes, as well as a viral attack in human PML), we did
not observe typical myelinosomes. This suggests that myeli-
nosome formation is indicative of a centripetal progression of
oligodendrocyte damage, possibly caused, or at least promoted, by
stressors that attack the cell’s periphery.
What might the local stressors be that induce myelinosome
formation in neuroinﬂammatory lesions? Our analysis indi-
cates that anti-myelin antibodies that bind and activate the
complement cascade are important mediators of myelinosome
formation. Such antibody–complement complexes could opso-
nize the myelin surface and make myelin a target for processes of
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Figure 4 | Oligodendrocyte pathology in actively demyelinating MS lesions spreads centripetally and involves myelinosome formation. (a) Overview of
a biopsy containing an actively demyelinating MS lesion stained for oligodendrocytes (NogoA, green), myelin (MBP, magenta) and nuclei (DAPI, cyan) that
is segmented in three different areas, the lesion centre, lesion rim and normal-appearing white matter (‘NAWM’). (b) Higher magniﬁcation views from
areas as deﬁned in a (also stained for Iba1 to reveal the activation of mononuclear phagocytes, cyan). Arrowheads, oligodendrocyte somata. (c–e)
Quantiﬁcation shows loss of myelin (c; lesion centre, n¼ 25 areas from 11 biopsies; rim of the lesion, n¼ 15 areas from 11 biopsies and NAWM, n¼ 10 areas
from 4 biopsies), while oligodendrocyte density is preserved (d; lesion centre, n¼ 23 areas from 11 biopsies; rim of the lesion, n¼ 29 areas from 11 biopsies
and NAWM, n¼ 16 areas from 7 biopsies) in areas of phagocyte inﬁltration (e; lesion centre, n¼ 5 areas from 3 biopsies; rim of the lesion, n¼ 6 areas from
3 biopsies and NAWM, n¼ 5 areas from 3 biopsies). (f) High-power view of a myelinosome (arrow; MBP, magenta; neuroﬁlament, white) in an actively
demyelinating MS lesion. (g) A comparably high density of myelinosomes is present in MS lesions, while only few are found in normal-appearing white
matter in MS and none are detected in cases of PML or in controls without inﬂammatory CNS disease (‘ctrl’, n¼ 3 autopsy cases; NAWM, n¼ 7
biopsies; MS lesion, n¼ 7 biopsies; PML, n¼4 autopsy cases). (a) Scale bar, 200 mm; (b) Scale bar, 20mm; (f) Scale bar, 10 mm. *Po0.05; **Po0.01
(Kruskal–Wallis followed by Dunn’s multiple comparison tests).
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bloodborne macrophages resulting in myelin stripping. This
interpretation is in line with previous work implicating mono-
cyte-derived macrophages as primary effectors of autoimmune
demyelination16. In contrast, results obtained in the cuprizone
model suggest that during toxic demyelination microglial cells
rather than bone-marrow derived macrophages remove myelin36.
Thus, there appears to be a mechanistic distinction between
phagocytic clearance of myelin debris during repair after toxic
oligodendrocyte injury36–38, and the inﬂammatory destabilization
and stripping of myelin that mediates primary myelin damage in
autoimmune disease models.
As antibody–complement complexes have also been detected in
actively demyelinating MS lesions4,39, it is conceivable that the
described cascade of myelin damage is also operational in human
MS40. Indeed our analysis of actively demyelinating MS lesions
showed that myelin was lost, while oligodendrocyte cell bodies
were preserved. Notably, we focused our analysis on early active
lesions, in which the presence of minor myelin constituents in the
phagocyte cytoplasm indicates that demyelination has been
initiated within the last 2–3 days21. While this time-frame
should limit the contribution of cell replacement processes, it is
difﬁcult to exclude that some of the oligodendrocytes in the lesion
centre and probably to a lesser extent at the lesion rim are
recruited from local progenitor pools. Still our results are at least
consistent with the view that in our samples of actively
demyelinating MS lesions, which were classiﬁed as pattern I or
pattern II lesions41, oligodendrocyte damage spreads in a
centripetal pattern, with myelin as the ﬁrst target of the immune
attack. In other types of lesions, distinct mechanisms might well
operate, as—for example—oligodendrocyte apoptosis is
prominent in pattern III lesions4,41 and has also been described
in particularly early, pre-phagocytic stages of actively
demyelinating central nervous system (CNS) lesions3,42,43. In
this context, it is interesting to note that lesions in PML, a disease
in which extensive oligodendrocyte apoptosis is induced by the JC
virus22, show no evidence of myelinosome formation. In any case,
as pattern I and II lesions presumably represent a majority of
actively demyelinating MS lesions4,44, our ﬁndings are relevant for
many cases of MS. It was in such MS lesions, where we found a
high density of myelinosomes comparable to that observed in
acute EAE lesions. Interestingly, myelinosomes were present on
normal-appearing axons in both EAE and MS lesions, indicating
that myelin damage can be initiated independently of axon
damage in neuroinﬂammatory lesions6 (Supplementary Fig. 7).
Taken together, our results suggest that the process of
myelinosome formation is also present in actively demyelinating
MS lesions, and that the presence of myelinosomes indicates the
centripetal spread of morphological alterations in oligodendro-
cytes due to an immune attack on their periphery. Thus,
interventions that target the cellular executors and molecular
mediators of myelinosome formation might help to prevent
myelin loss in MS.
Methods
Transgenic mice. C57BL/6 and Biozzi ABH mice were obtained from Janvier Labs
and from Envigo, respectively. Reporter mice on a C57BL/6 background were
crossed with Biozzi ABH mice to obtain (F1) Thy1-YFP16/Biozzi ABH mice, in
which neurons were ﬂuorescently labelled12; PLP-GFP/Biozzi ABH mice, in which
the PLP promoter localizes the GFP speciﬁcally to oligodendrocytes10 and
CCR2RFP/þ /Biozzi ABH, in which circulating monocytes are labelled with RFP16.
For the experiments, adult animals between 6 and 12 weeks of age from both sexes
were used. All animal experiments were performed in accordance with regulations
of the relevant animal welfare acts and protocols approved by the respective
regulatory bodies (Regierung von Oberbayern).
EAE induction. Active EAE was induced in adult mice by immunization with
recombinant MOG or a synthetic MOG peptide. Biozzi ABH and Biozzi ABH/BL6
animals were immunized as described previously7 and received an emulsion
containing 50 mg of puriﬁed recombinant MOG (N1-125) in complete Freund’s
adjuvant (containing 5–10mgml 1 Mycobacterium tuberculosis H37 Ra,
Sigma-Aldrich) at day 0 and day 7. On day 0, 1, 7 and 8 following immunization,
50 ng of pertussis toxin was administered intraperitoneally. Mice on a C57BL/6
background were immunized with either 200 mg of MOG peptide (N35-55) in
complete Freund’s adjuvant as previously described45, followed by the injection
of 400 ng of pertussis toxin at day 0 and day 2 after immunization; or 200 mg of
recombinant rodent MOG (N1-125) in complete Freund’s adjuvant, followed by
the injection of 250 ng of pertussis toxin at day 0 and day 2 after immunization; or
100 mg of recombinant human MOG in complete Freund’s adjuvant as previously
described46, followed by the injection of 240 ng of pertussis toxin at day 0 and day 2
after immunization.
After immunization, mice were weighed daily and neurological deﬁcits were
evaluated according to the following EAE score: 0, no clinical signs; 0.5, partial tail
weakness; 1, tail paralysis; 1.5, gait instability or impaired righting ability; 2, hind
limb paresis; 2.5, hind limb paresis with dragging of one foot; 3, total hind limb
paralysis; 3.5, hind limb paralysis and fore limb paresis; 4, hind limb and fore limb
paralysis; 5, death.
Ethidium bromide model. Chemical induction of demyelination was performed in
PLP-GFP/Biozzi ABH mice as described previously47. Brieﬂy, mice received a
single injection of 0.5 ml of ethidium bromide (1mgml 1 ) into the ventral
funiculus of the lumbar spinal cord, at a depth of 1.2mm from the meningeal
surface. Control animals were injected with 0.5 ml of saline using the same protocol.
Mice were sacriﬁced 4 days after the injection.
Immunohistochemistry. Animals were euthanized with isoﬂuorane and perfused
transcardially with 20ml of saline solution followed by 20–30ml of 4% paraf-
ormaldehyde (PFA) in 0.1M phosphate buffer. Spinal cords were dissected out and
post-ﬁxed in 4% PFA overnight at 4 C. To cryo-protect the tissue, it was incubated
in 30% sucrose in 1 PBS for 48 h before embedding the specimens in Tissue-
Tek (O.C.T., Sakura Finetek Europe B.V.) compound and freezing it at  20 C.
Subsequently 20–30 mm thick longitudinal sections of the lumbar spinal cord were
cut and stained free-ﬂoating. The sections were rinsed three times for 10min in
1 PBS at room temperature and then incubated for 1 h at room temperature with
10% goat serum. To stain myelin, a rabbit anti-MBP antibody was applied after
cold methanol pre-treatment and to label phagocytes, a rabbit anti-Iba1 (antibody
dilution 1:200, Wako) was used. The sections were ﬁrst incubated overnight at 4 C
in a solution containing 1% goat serum/ 0.1% NaN3/ 0.5% Triton/ 1 PBS in
which the primary antibody was diluted. The sections were washed three times
with 1 PBS and incubated with a goat anti-rabbit Alexa 594 secondary antibody
(dilution 1:1,000, Thermo Fisher Scientiﬁc) for 4 h at 4 C in a solution containing
1% goat serum/ 0.5% Triton/ 1 PBS. All samples were counterstained with the
Nissl-like dye, Neurotrace 640/660 (1:500, Thermo Fisher Scientiﬁc). After staining,
the samples were mounted with Vectashield and covered with a coverslip glass
sealed with nail polish.
Single-cell labelling. Healthy and immunized PLP-GFP/Biozzi ABH animals were
used to study the morphology of single oligodendrocytes. Seven days after
immunization (in case of EAE animals), mice were ﬁrst anesthetized with ketamine
and xylazine (ketamine 87mg kg 1, Bremer Pharma GmbH; xylazine 13mg kg 1,
Serumwerk Bernburg AG) and the dorsal spinal cord was exposed as previously
described48. Then 0.5 ml of rabies virus SAD DG mCherry was injected in the white
matter of the lumbar spinal cord with a glass capillary at a depth of 0.2–0.4mm.
Each mouse received two injections. Animals were then killed 9 days after rabies
virus injections. For two-photon time-lapse experiments, mice were imaged at
weight loss, at the onset of clinical symptoms, and at 1 or 2 days after the onset,
and killed after the imaging session (6–9 days after rabies virus injection).
Quantiﬁcations of the process number and length of single oligodendrocytes
were performed manually based on 3D-rendered confocal images stacks (rendering
was performed with Imaris Scientiﬁc 3D/4D Image processing software). The total
number of primary processes exiting the soma was counted and expressed as the
average number of processes per OL; the length of all the processes (primary and
other) was measured and divided by the number of processes to obtain average
process length. Images from both healthy and EAE groups were analyzed by an
evaluator blinded to the group status of the images.
Histopathology. For histopathological analysis Biozzi ABH, Biozzi ABH/BL6 and
Thy1-YFP16/BL6 mice were transcardially perfused with 4% PFA and parafﬁn-
embedded according to standardized protocols. Stainings were done on 3–4 mm
thick cross-sections of lumbar, thoracic and cervical spinal cords. LFB/PAS-
staining was performed to assess demyelination, and the demyelinated area of
spinal cross-sections (expressed as % of total white matter) was measured manually
using Pannoramic Viewer 1.15 software (http://www.3dhistech.com/pannor-
amic_viewer). Images from both healthy and EAE groups were analyzed by an
evaluator blinded to the group status of the images.
To assess axonal pathology, sections were stained with Bielschowsky silver
impregnation. For automatic quantiﬁcation of axon density a custom ruleset was
created using Deﬁniens Developer software (Deﬁniens). First, regions of interest
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were exported from 400 slide scans in full resolution using Pannoramic viewer.
On these, tissue-background separation was performed and the total area of
tissue calculated. Axons were detected and nuclei excluded based on their
respective characteristic spectral properties (for example, brightness, RGB
channel distribution) and morphology (for example, surrounded by cytoplasm).
The number of axons was quantiﬁed within a lesion and in the respective perilesion
area (considered as normal-appearing white matter). Axon numbers were ﬁrst
exported as axon density [#mm 2], and subsequently expressed in % normalized
to the NAWM.
Immunostainings were carried out after antigen retrieval with microwave
pre-treatment (citrate buffer, pH 6). Non-speciﬁc antibody binding was inhibited
with 10% FCS in PBS. Immunostaining was done using following primary
antibodies: rat anti-Mac3 (macrophages/activated microglia, 1:200, BD), T cells
with an anti-CD3 (T cells, 1:50, Serotec). Bound primary antibodies were visualized
by an avidin-biotin technique with 3,30-diaminobenzidine 3 (DAB) as chromogen
(haemalaun counterstaining of nuclei). Stained tissue sections were scanned at
 200 magniﬁcation using a panoramic 250 ﬂash slide scanner (3D Histech Ltd).
For the quantiﬁcation of immune cell density, images were opened with the
software Pannoramic Viewer and exported as TIFF-ﬁles to ImageJ. To count the
number of Mac3þ cells and the number of CD3þ cells, the ‘cell counter’ plugin
was used.
Human tissue analysis. For histopathological analysis, brain sections derived
from biopsies of MS lesions (classiﬁed as early active pattern I or II lesions
as described previously4; for details see Supplementary Table 1), from autopsy
cases of PML or from control white matter derived from autopsy cases without
neuroimmunological diseases were ﬁxed in 4% PFA and embedded in parafﬁn
according to standardized protocols. Their use for scientiﬁc purposes was in
accordance with institutional ethical guidelines and approved by the ethics
committee of the University of Go¨ttingen (Germany). Informed consent was
obtained from all subjects. Immunostainings were carried out on 2–3 mm thick
sections after antigen retrieval with microwave pre-treatment (citrate buffer, pH 6).
Non-speciﬁc antibody binding was inhibited with 10% FCS in PBS. The following
primary antibodies were used: rabbit anti-myelin basic protein (MBP; 1:1,000,
Dako), mouse anti-NogoA (oligodendrocytes, 1:10,000, mAb 11C7, a generous gift
from M.E. Schwab, Brain Research Institute, ETH and University of Zu¨rich) and
Alexa647 pre-labelled rabbit anti-Iba1 (microglia/macrophages; 1:1,000, WAKO,
antibody labelling was done with Alexa Fluo 647 antibody labelling kit, Molecular
Probes) and anti-Neuroﬁlament 200 (axons, 1:50, Dako). Bound primary
antibodies were visualized using appropriate species-speciﬁc Alexa488- or
Alexa555-conjugated secondary antibodies (all from Jackson ImmunoResearch
Laboratories Inc) and counterstained with Neurotrace 435 (Thermo Fisher
Scientiﬁc) or DAPI. Stained tissue sections were scanned at  400 magniﬁcation
using a panoramic 250 ﬂash slide scanner.
Confocal microscopy. Samples were scanned on an upright FV1000 confocal
microscopy system (Olympus) equipped with  10/0.4 air,  20/0.85 and 
60/1.42 oil immersion objectives. Images were acquired using standard ﬁlter sets
and processed with ImageJ or Adobe Photoshop software.
Molecular manipulation of demyelination. To assess the contribution of
antibodies and the complement system to myelinosome formation we used
Thy1-YFP16/BL6 mice. To induce primary demyelination the anti-MOG mono-
clonal antibody 8.18C5 (puriﬁed hybridoma supernatant with 35 mg of mouse
IgG per injection, kindly provided by Dr. Krishnamoorthy, Max-Planck Institute of
Biochemistry) was injected intraperitoneally for three days starting from disease
onset18. An IgG1 isotype control antibody (100 mg per injection) was injected at
similar time-points in the control group. To deplete complement 25 mg of Cobra
Venom Factor49 (1 mgml 1, Quidel Corporation) was injected at the day of disease
onset followed by three injections with anti-MOG monoclonal antibody 8.18C5
(at Onset, Onsetþ 1, Onsetþ 2). All mice were weighed and scored daily
(as described above) and sacriﬁced three days after onset of clinical signs.
In vivo imaging. After anaesthesia with ketamine and xylazine (ketamine
87mg kg 1, xylazine 13mg kg 1) or with a combination of medetomidin
(0.5mg kg 1, Orion Pharma), midazolam (5mg kg 1, Ratiopharm) and fentanyl
(0.05mg kg 1, B. Braun Melsungen AG) animals were placed on a heating pad for
15min. Tracheotomy and intubation were performed to minimize breathing
artefacts by controlling respiration during imaging and the dorsal spinal cord was
surgically exposed as previously described7,13,48; the opening was constantly
superfused with artiﬁcial cerebrospinal ﬂuid (aCSF; prepared according to the
protocol provided by Alzet, http://www.alzet.com/products/guide_to_use/
csf_preparation.html). A spinal clamping device (spinal adaptor; Narishige STS-A)
was used to stabilize the animal and an agarose well (4% agarose) surrounding the
spinal opening was formed to keep the spinal cord covered with aCSF and to
incubate with vital dyes as previously described13. For in vivo imaging, we used the
following two-photon microscopes: a custom-built setup based on an Olympus
FV300 and a commercially available Olympus FV1200 MPE. Both microscopes
were equipped with femto-second pulsed Ti:Sapphire lasers, which were attenuated
by a polarization-based beam splitter or acousto-optical modulators, respectively.
To study myelin damage in vivo, immunized Thy1-YFP16/Biozzi ABH mice
with an EAE score Z2.5 were imaged. After bath application of MitoTracker Red
(Thermo Fischer Scientiﬁc) at a concentration of 8 mM for 30min (an application
scheme that primarily reveals myelin13) the spinal cord was carefully washed with
aCSF before the imaging session. The laser was tuned to 910 nm to excite both YFP
(axons) and MitoTracker Red (myelin) and ﬂuorescence emission was detected
using a green/red ﬁlter set (BA495-540, BA575-630). The presence of damaged
axons, myelin debris and a high density of nuclei, labelled by the nuclear dye
POPO-1 Iodide (Thermo Fischer Scientiﬁc) as previously described13, were used to
identify inﬂamed areas of the dorsal white matter where imaging was performed.
To monitor changes in myelin morphology over time, image stacks were acquired
every 10min for several hours. Time-lapse images were acquired with a  25/1.25
water immersion objective with a pixel size of 0.082 mmpixel 1 and a pixel dwell
time of 2 ms.
To study oligodendrocyte damage at the single-cell level, PLP-GFP/Biozzi ABH
mice were immunized and injected with SADDG-mCherry rabies virus
(as described above). Mice were imaged at weight loss, at the onset of clinical
symptoms or one and two days later. The laser was tuned to 840 nm to excite GFP
(oligodendrocytes) and to 910 nm to visualize the virus-induced expression of
mCherry. Single oligodendrocytes were imaged for 270–330min; time-lapse images
were obtained with a  25/1.25 water immersion objective and a pixel dwell time
of 2 ms.
Similar imaging experiments were performed in healthy animals with or
without SADDG-mCherry rabies virus injection, to make sure that the morpho-
logical changes in myelin structure and oligodendrocyte processes were not due to
anaesthesia, surgery, photo-, dye-or virus-toxicity. In control mice neither signs
of myelin alterations (n¼ 3 mice each imaged for 2–3 h) nor other signs of
oligodendrocyte damage (n¼ 5 mice each imaged for 270–300min) were detected
even after several hours of imaging.
Tissue ﬁxation for correlated light and electron microscopy. Thy1-YFP16/
Biozzi ABH animals with an EAE score of Z2.5 were transcardially perfused with
2.5% electron microscopy grade glutaraldehyde (GA) and 2% PFA in 0.1M
phosphate buffer (pH 7.2). The spinal cords were isolated and post-ﬁxed in
2.5% GA/ 2% PFA overnight. The tissue was then embedded in 4% agarose and cut
into thick sections (100–150 mm) using a vibratome. To visualize myelin, Mito-
Tracker Red (at a concentration of 8 mM) was applied for 5 h at room temperature.
Then sections were carefully washed three times for 15min in 1 PBS and
mounted in 1 PBS under a coverslip in imaging chambers built with paraﬁlm
spacers on a glass slide15.
NIRB and electron microscopy. MitoTracker Red-labelled samples were imaged
on an Olympus FV1200 MPE using confocal laser excitation at 515 and 559 nm
(ExDM405/488/559/635, BA505-540, BA575-620) to detect myelinosomes. Once
the myelin out-folding was located, NIRB marks were placed using the Ti:Sapphire
laser tuned to 910 nm and a pixel dwell time of 10 ms pixel 1 with a  25/1.05
water objective15. To facilitate the detection of the structure of interest a bigger box
of 100 100 mm was burnt 2 mm above the myelinosome. The serial sectioning
of the tissue containing the NIRB marks was performed as described previously15.
Electron micrographs were obtained at 120 KV using a JEOL JEM-1400 equipped
with a Gatan Ultrascan 1000XP camera. Images were then processed with the
software Reconstruct (http://synapses.clm.utexas.edu/tools/reconstruct/
reconstruct.stm), while for rendering we used 3DS Max software (Autodesk).
Preparation and microscopy of high-pressure frozen samples. MOG-immu-
nized Biozzi AbH mice and mice fed with 0.2% of the copper chelator cuprizone,
were killed during the progressive phase of EAE (about 25–30 days after immu-
nization) or 2 or 3 weeks after cuprizone feeding, respectively, by cervical
dislocation and the spinal cord was quickly dissected. After embedding in 10%
gelatine (Twee Torens), 200mm thick cross-sections of the spinal cord were cut
with the help of the Leica vibratome VT1200S. The sections were assessed
macroscopically and lesion-containing regions were cryoﬁxed in 20% poly(vinyl-
pyrrolidinone) (Sigma-Aldrich) using the high-pressure freezer Leica HPM100.
The tissue samples were then freeze-substituted using the ‘tannic acid and
OsO4’-protocol in a semi-automated fashion on the Leica AFS II as described
previously27,28. After Epon embedding of the tissue, the samples were cut with
a Leica Ultracut S ultramicrotome into 0.5 mm semithin sections. These cross-
sections were subsequently stained with methylene blue/Azure II blue for 1min to
visualize myelin (lipid-rich) areas in the tissue. Areas devoid of this staining were
considered regions of interest that contain lesions sites. Ultrathin sections of 50 nm
thickness of these areas were cut thereafter and contrasted with 4% uranylacetate
for 20min at room temperature28 (SPI-Chem). Electron micrographs were
obtained on a LEO EM912AB electron microscope (Zeiss) equipped with an
on-axis 2k CCD-camera (TRS) using the ITEM (Olympus) software.
Image processing and analysis. To analyze the spread of oligodendrocyte
damage, PLP-GFP/Biozzi ABH mice were immunized and perfused with 4% PFA at
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weight loss, onset of clinical symptoms, two days after onset, and 20 days after the
second bout of EAE. Longitudinal sections of the lumbar spinal cord were cut and
stained free-ﬂoating with an anti-MBP antibody and NeuroTrace 640/660 as
described above. For each animal, we analyzed three lesions (each lesion was
separated into the following regions: lesion centre, lesion border and adjacent
normal-appearing white matter). ImageJ was used for processing and quantiﬁca-
tion of the areas. The ‘cell counter’ plugin was used to count the number of
oligodendrocyte cell bodies and the number of all nuclei. The length of myelin was
traced using the ‘freehand line’ tracing tool and the ‘measure’ plugin, and expressed
in mm. The quantiﬁcation of myelinosome density in Thy1-YFP16/Biozzi ABH at
different time-points of the disease course, in Thy1-YFP16/BL6 mice treated with
8.18C5/ CVFþ 8.18C5 or isotype control antibody, mice immunized with
recombinant MOG or human MOG, and mice injected with ethidium bromide, as
well as in human samples (MS, control and PML cases), was performed as follows.
Sections were stained with anti-MBP as described above. High magniﬁcation
confocal images were taken with a  60/1.42 oil objective (with  4 zoom at
0.082 mmpixel 1) at the border of the lesions. Quantiﬁcation was performed using
ImageJ and its ‘trace’ and ‘measure’ plugins: the length of each axon in the stack
was measured and the density of myelinosomes was expressed as number of
myelinosomes per total mm of axons analyzed. Myelinosomes were deﬁned as
bulb-like myelin out-foldings that were still connected to the main myelin sheath.
For the analysis of the human samples, images were opened with the software
Pannoramic Viewer (http://www.3dhistech.com/pannoramic_viewer) and exported
as TIFF-ﬁles to ImageJ. To count the number of Iba1þ cells and the number of
NogoAþ cells, the ‘cell counter’ plugin was used. The length of myelin was
measured with the ‘trace’ and ‘measure’ plugins, as described before. The density of
myelinosomes was measured as described above for the murine model.
Statistical analysis. Results are given as mean±s.e.m. Data sets were tested for
normal distribution using the D’Agostino–Pearson test. Those data sets for which a
normal distribution could be assumed were then compared using student t-test or,
if there were more than two samples, analyzed using one-way ANOVA followed by
Bonferroni’s multiple comparison tests. When normal distribution could not be
assumed, the nonparametric Mann–Whitney test or, if there were more than two
samples, the Kruskal–Wallis followed by Dunn’s multiple comparison tests were
chosen. Statistical analyses were performed with GraphPad Prism software.
Data availability. All data generated or analyzed during this study are included in
the published article (and its Supplementary Information ﬁle) or are available from
the corresponding authors upon reasonable request.
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